Refinement of Catalyst hypotheses using simplex optimisation

Journal of Computer-Aided Molecular Design

Volumn 14, Issue 6, 2000, Pages 545-557

  Norinder, Ulf ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

3D QSAR; ACE; Catalyst; Citest; HIVPR; Hypothesis; Receptor information; Simplex optimisation; SQEP

Indexed keywords

CATALYST ACTIVITY; COMPUTATIONAL CHEMISTRY; STATISTICAL METHODS;

3D-QSAR; ACE; CITEST; CROSS VALIDATION; HIVPR; HYPOTHESIS; RECEPTOR INFORMATION; SIMPLEX OPTIMIZATION; SQEP; ]+ CATALYST;

ENZYME INHIBITION;

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROTEINASE INHIBITOR; SQUALENE MONOOXYGENASE;

ARTICLE; CALCULATION; CATALYST; CHEMICAL STRUCTURE; COMPUTER PROGRAM; CONTROLLED STUDY; ENZYME INHIBITION; GEOMETRY; HYPOTHESIS; METHODOLOGY; MODEL; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 0033921869     PISSN: 0920654X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008191129541     Document Type: Article

References (20)

1. Doweyko, A.M., J. Med. Chem., 31 (1988) 1396.
2. Ghose, A., Crippen, G., Revankar, G., McKernan, P., Smee, D. and Robbins, R., J. Med. Chem., 32 (1989) 746.
3. Cramer, R.D., Patterson, D.E. and Bunce, J.D., J. Am. Chem. Soc., 110 (1988) 5959.
4. Norinder, U., J. Comput.-Aided Mol. Design, 7 (1993) 671.
5. Floersheim, P., Nozulak, J. and Weber, J., In Wermuth, C.G. (Ed.) Trends in QSAR and Molecular Modelling 92 (Proceedings of the 9th European Symposium on Structure-Activity Relationships: QSAR and Molecular Modelling), ESCOM, Leiden, 1993, pp. 227-232.
6. Kubinyi, H. (Ed.) 3D QSAR in Drug Design: Theory, Methods and Applications, ESCOM, Leiden, The Netherlands, 1993.
7. Klebe, G., Abraham, U. and Mietzner, T., J. Med. Chem., 37 (1994) 4130.
8. Silverman, B.D. and Platt, D.E., J. Med. Chem., 39 (1996) 2129.
9. Molecular Simulations Inc., San Diego, CA, USA.
10. http://www.msi.com/science/online/references/rdd_msi_pubs. html
11. http://www.msi.com/science/online/references/catalyst_pubs. html
12. Supplied as Application Note data as part of the Catalyst software.
13. Sprague, P.W., Building a Hypothesis for Angiotensin Converting Enzyme Inhibition, MSI application note.
14. Wold, S., Technometrics, 20 (1979) 379.
15. Hoffmann, R.D. and Sprague, P.W., Building a Hypothesis for Competitive Inhibition of Rat Liver Squalene Epoxidase, MSI application note.
16. Tummino, P.J., Prasad, J.V.N.V., Ferguson, D., Nouhan, C., Graham, N., Domagala, J.M., Ellsworth, E., Gajda, C., Hagen, S.E., Lunney, E.A., Para, K.S., Tait, B.D., Pavlovsky, A., Erickson, J.W., Gracheck, S., McQuade, T.J. and Hupe, D.J., Bioorg. Med. Chem., 4 (1996) 1401.
17. Erickson, J.W., Neidhart, D.J., VanDrie, J., Kempf, D.J., Wang, X.C., Norbeck, D.W., Plattner, J.J., Rittenhouse, J.W., Turon, M., Wideburg, N., Kohlbrenner, W.E., Simmer, R., Helfrich, R., Paul, D.A. and Knigge, M., Science, 249 (1990) 527.
18. Press, W.H., Teukolsky, S.A., Vetterling, W.T. and Flannery, B.P., Numerical Recipes in FORTRAN: The art of Scientific Computing, 2nd ed., Cambridge University Press, Cambridge, MA, 1992, pp. 423-436.
19. Norinder, U., in-house software.
20. Box, G.E.P., Hunter, W.G. and Hunter J.S., Statistics for Experimenters, Wiley, New York, NY, 1978.